Apigenin: Antihypertensive Effects and Underlying Mechanisms — A Comprehensive Review

Abstract: Apigenin, a ubiquitous dietary flavone from vegetables, fruits and herbal teas, exhibits multi-target hypotensive effects, yet its poor water solubility limits oral bioavailability and industrial translation. Previous reviews only summarized its general bioactivities and anti-atherosclerotic effects, without comprehensively analyzing its antihypertensive mechanisms. Most evidence derives from preclinical studies; human trials merely use crude celery seed extracts instead of purified apigenin, lacking reliable clinical proof for its antihypertensive efficacy. This review summarizes apigenin’s sources, chemical properties, safety and solubility-enhanced delivery systems to support functional food exploitation. We elaborate four core antihypertensive pathways, and also point out translational bottlenecks and propose strategies including food-grade nanoformulation and standardized clinical trials. This work links preclinical mechanisms to food industry application, providing theoretical evidence for developing apigenin-enriched functional foods for hypertension adjuvant intervention. Keywords: apigenin, hypertension, antioxidant, anti-inflammation, blood pressure, flavone

Authors

Institutions

Publication Details

Journal
Drug Design Development and Therapy
Published
2026-10-31
DOI
https://doi.org/10.2147/dddt.s629109
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apigenin: Antihypertensive Effects and Underlying Mechanisms — A Comprehensive Review

Xiaolin Liao, Huaguan Lu, Hangxing Huang, Jing Li et al.
Drug Design Development and Therapy
Flavonoids in Medical Research
article

Apigenin: Antihypertensive Effects and Underlying Mechanisms — A Comprehensive Review

Xiaolin Liao, Huaguan Lu, Hangxing Huang, Jing Li, Yueping Jiang, Junlong Cai, Hongfang Li
article en

Abstract

Abstract: Apigenin, a ubiquitous dietary flavone from vegetables, fruits and herbal teas, exhibits multi-target hypotensive effects, yet its poor water solubility limits oral bioavailability and industrial translation. Previous reviews only summarized its general bioactivities and anti-atherosclerotic effects, without comprehensively analyzing its antihypertensive mechanisms. Most evidence derives from preclinical studies; human trials merely use crude celery seed extracts instead of purified apigenin, lacking reliable clinical proof for its antihypertensive efficacy. This review summarizes apigenin’s sources, chemical properties, safety and solubility-enhanced delivery systems to support functional food exploitation. We elaborate four core antihypertensive pathways, and also point out translational bottlenecks and propose strategies including food-grade nanoformulation and standardized clinical trials. This work links preclinical mechanisms to food industry application, providing theoretical evidence for developing apigenin-enriched functional foods for hypertension adjuvant intervention. Keywords: apigenin, hypertension, antioxidant, anti-inflammation, blood pressure, flavone

Drug Design Development and TherapyVol. Volume 20
Huaihua University (CN), Zunyi Medical University (CN), Xiangya Hospital Central South University (CN), Affiliated Hospital of Zunyi Medical College (CN), Guangxi Academy of Sciences (CN)
Openalex Percentile: Top 13%
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Apigenin: Antihypertensive Effects and Underlying Mechanisms — A Comprehensive Review — Xiaolin Liao, Huaguan Lu, et al. · Drug Design Development and Therapy (2026) | TGRS Research Map | TGRS